Upregulation of CD40 and CD40 ligand expression in IgE-associated cutaneous diseases

B Hermes1, M Worm, F Nowak

  • 1Department of Dermatology, Virchow-Klinikum, Humboldt-Universität, Berlin, Germany.

Acta Dermato-Venereologica
|December 12, 1997
PubMed

Insights

Skin cells in atopic dermatitis (AD) and scabies show increased IgE and CD40/CD40L expression, suggesting the skin may contribute to IgE synthesis, unlike chronic urticaria.

Area of Science:

  • Immunodermatology
  • Cutaneous Immunology
  • Allergy Research

Background:

  • Immunoglobulin E (IgE) is central to allergic skin diseases.
  • CD40 and CD40 Ligand (CD40L) are crucial for B-cell IgE synthesis.
  • Understanding IgE-associated cutaneous disease requires examining these molecules in skin.

Purpose of the Study:

  • To investigate the expression of IgE, its receptors (Fc epsilon RI, Fc epsilon RII), and CD40/CD40L in various skin conditions.
  • To compare these expressions in atopic dermatitis (AD), scabies, and chronic urticaria with normal skin.
  • To analyze these markers in a dermopathic lymph node versus normal lymphatic tissue.

Main Methods:

  • Immunohistochemistry was employed to detect protein expression.
  • Analysis included skin samples from AD, scabies, chronic urticaria patients, and healthy controls.
  • Lymphatic tissue from a patient with AD and a normal donor was also examined.

Main Results:

  • Increased expression of IgE, Fc epsilon RI, Fc epsilon RII, CD40, and CD40L was observed in the skin of AD and scabies patients compared to normal skin.
  • These increases were localized to the dermis and partly the epidermis.
  • Chronic urticaria skin showed no significant changes in these markers; lymphatic tissue showed CD40/CD40L in both normal and AD cases, but IgE/Fc epsilon RI primarily in AD.

Conclusions:

  • Elevated IgE/Fc epsilon RI and associated CD40/CD40L expression in AD and scabies skin suggests a role for cutaneous tissue in IgE synthesis.
  • The findings indicate that skin, alongside lymphatic tissue, may actively participate in the pathogenesis of IgE-mediated skin diseases.
  • This highlights potential therapeutic targets within the skin microenvironment for allergic dermatoses.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...